Product image of Ircolon (Trimebutine Maleate) supplied by GNH India

Ircolon

Active Ingredient:
Trimebutine Maleate
Origin:
EU

Ircolon (Trimebutine Maleate)

Trimebutine maleate, the active ingredient in Ircolon, is a spasmolytic / gastrointestinal motility modulator presented as an oral formulation for oral use. It is employed to manage functional gastrointestinal disorders such as irritable bowel syndrome, functional dyspepsia and related abdominal pain in adult patients.

GNH India supplies Ircolon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Polfarmex S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ircolon is a spasmolytic that acts on gastrointestinal motility disorders.

  • Irritable bowel syndrome: helps normalize bowel movements and reduces abdominal discomfort.
  • Functional dyspepsia: alleviates post‑prandial fullness and upper abdominal pain.
  • Abdominal pain associated with gastrointestinal dysmotility: reduces visceral hypersensitivity and eases pain episodes.

How It Works

  • Trimebutine maleate modulates gastrointestinal motility by acting as a mu‑opioid receptor agonist and antagonist. This dual activity helps normalize dysregulated peristalsis, reduces visceral hypersensitivity, and restores coordinated muscle contractions throughout the GI tract, thereby improving symptoms of functional bowel disorders.

Side Effects

Adverse reactions may vary in frequency and severity.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Abdominal discomfort: transient cramping or bloating.
  • Dry mouth: reduced salivation.
  • Headache: mild tension‑type headache.
  • Dizziness: occasional light‑headedness.
  • Constipation: reduced bowel frequency.

Serious or Rare Side Effects

  • Severe allergic reaction (anaphylaxis): rash, swelling, breathing difficulty.
  • Cardiac arrhythmia: irregular heartbeat requiring medical attention.
  • Hepatic dysfunction: elevated liver enzymes or jaundice.
  • Neutropenia: marked reduction in white blood cells.
  • Hypotension: significant drop in blood pressure.

Precautions & Warnings

Patients should be aware of specific safety considerations before using Ircolon.

  • Hypersensitivity: avoid if known allergy to trimebutine or excipients.
  • Hepatic impairment: use with caution; monitor liver function.
  • Renal impairment: dose adjustment may be required in severe renal disease.
  • Concomitant opioid use: monitor for additive effects on gastrointestinal motility.
  • Severe constipation: discontinue if bowel obstruction is suspected.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Trimebutine may interact with other medicines; awareness of interaction severity is important.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase trimebutine levels.
  • Other opioid receptor agonists/antagonists: risk of additive gastrointestinal effects.
  • MAO inhibitors: potential for exaggerated autonomic responses.

Moderate Interactions (Monitor Closely)

  • Antacids containing aluminum or magnesium: may reduce absorption.
  • Antihistamines with anticholinergic activity: could enhance antispasmodic effect.
  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): monitor for gastrointestinal irritation.
  • Other pro‑kinetic agents: assess for overlapping therapeutic actions.

Frequently Asked Questions

Ircolon, containing trimebutine maleate, is indicated for functional gastrointestinal disorders such as irritable bowel syndrome, functional dyspepsia, and abdominal pain linked to gastrointestinal dysmotility. It helps normalize bowel movements and reduces visceral discomfort in adult patients.

Trimebutine maleate acts as a mu‑opioid receptor agonist and antagonist. This dual action modulates the enteric nervous system, balancing peristaltic activity, reducing visceral hypersensitivity, and promoting coordinated muscle contractions throughout the gastrointestinal tract.

The specific dose of Ircolon is determined by the prescribing clinician based on the individual’s condition, severity, and response to therapy. Patients should follow the dosage instructions provided by their healthcare professional.

Safety data for trimebutine maleate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To request Ircolon, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ircolon’s unique mechanism as a mu‑opioid receptor modulator distinguishes it from traditional anticholinergic spasmolytics. While both classes reduce gastrointestinal spasm, trimebutine also normalizes dysmotility and visceral sensitivity, offering a broader therapeutic profile for functional bowel disorders.

Ircolon should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Ircolon is taken orally, usually with a glass of water. The exact administration schedule—such as timing relative to meals—should follow the prescribing clinician’s guidance to achieve optimal therapeutic effect.

Serious adverse events, although rare, can include severe allergic reactions (anaphylaxis), cardiac arrhythmias, hepatic dysfunction, neutropenia, and significant hypotension. Patients should seek immediate medical attention if they experience any of these symptoms.

Ircolon is contraindicated in individuals with known hypersensitivity to trimebutine maleate or any formulation excipients. Caution is also advised for patients with severe hepatic or renal impairment, uncontrolled cardiac conditions, or those taking interacting medications listed under major interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Trimebutine Maleate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT